M&A Corner
Univercells Technologies Acquired by Donaldson Company03 Jul 2023
Univercells Technologies (UT), a leading provider of biomanufacturing technologies for advanced therapies and vaccines, has been acquired by Donaldson Company.... Continue Reading
|
Enzolytics, Inc. Reports Amendment to Non-Binding Term Sheet with the Special Purpose Acquisition Company Sagaliam Acquisition Corp.03 Jul 2023
Enzolytics and Sagaliam Acquisition have amended their non-binding term sheet for the sale of Biogenysis and Virogentics. The combined purchase... Continue Reading
|
Immunome and Morphimmune Announce a Definitive Merger Agreement and Simultaneous Private Placement Investment of $125 Million to Develop Targeted Cancer Therapies.03 Jul 2023
Immunome and Morphimmune have entered into a definitive merger agreement to create a biopharmaceutical company focused on developing antibody therapeutics... Continue Reading
|
Tevogen Bio to Become Publicly Listed on NYSE via Business Combination with Semper Paratus Acquisition Corporation.03 Jul 2023
Tevogen Bio Inc., a specialty immunotherapy biotech company, is set to merge with Semper Paratus Acquisition Corporation, a special purpose... Continue Reading
|
Lilly to Acquire Sigilon Therapeutics03 Jul 2023
Eli Lilly has announced its acquisition of Sigilon Therapeutics, a biopharmaceutical company focused on developing functional cures for acute and... Continue Reading
|
Enovis™ Completes Acquisition of Novastep®03 Jul 2023
Enovis Corporation has completed its acquisition of Novastep, a global developer of foot and ankle solutions. The acquisition strengthens Enovis’... Continue Reading
|
Alpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business Combination03 Jul 2023
Alpha Healthcare Acquisition Corp. III (ALPA) has signed a non-binding letter of intent to acquire a commercial stage regenerative medicine... Continue Reading
|
Precision for Medicine Acquires Baseline Controls, Expanding the Company’s End-to-End Manufacturing Solutions for Life Science Companies03 Jul 2023
Precision for Medicine, a biomarker-driven clinical research organization, has acquired Baseline Controls, a company specializing in project feasibility, execution planning,... Continue Reading
|
Define Ventures Seeks to Invest in Digital Health After $460M Raise03 Jul 2023
Venture firm Define Ventures has raised $460 million for its Fund III and Opportunities Funds to expand its investments in... Continue Reading
|
Alfie Health Raises $2.1M for AI-Powered, Virtual Obesity Clinic03 Jul 2023
Alfie Health, a virtual clinic for patients with obesity, has raised $2.1 million in funding led by Y Combinator and... Continue Reading
|